Home LiteratureArticle Details
PMID: 1833074 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The coexpression of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of cell cycle.

Cellular immunology ·Vol. 138 ·No. 1 ·1991-11-00 ·Pages 197-206

LaSalle JM, Hafler DA

Abstract

The tyrosine phosphatase CD45 is alternatively spliced to generate isoforms of different molecular weights (180-220 kDa) which are differentially expressed on hematopoietic cells. Monoclonal antibodies reacting with either the 180-kDa (UCHL-1, CD45RO) or the 200- to 220-kDa (2H4, CD45RA) isoform have been used to subdivide T cell populations based on their expression of one or the other of these two epitopes. CD45RA T cells have "naive" characteristics of unresponsiveness to recall antigens and prominence in cord blood, while CD45RO T cells are considered "memory" T cells because they proliferate to recall antigens and increase following PHA activation of cord blood. However, we have recently demonstrated the expression of the CD45RA isoform on a subpopulation of CD45RO+ T cell clones, suggesting that CD45RA is not a universal marker for naive T cells. Using propidium iodide staining of the DNA to determine cell cycle stage, we now show that CD45RA expression is significantly higher on T cell clones during the S, G2, and M stages of cell cycle when compared to CD45RA expression on cells in Go and G1. Furthermore, CD45RA expression on cells undergoing mitosis is not limited to long-term activated T cell clones, as uncultured peripheral blood T cells in the S/G2/M phase express significantly more CD45RA. The percentage of T cells coexpressing CD45RA and CD45RO also increases following PHA activation, indicating that T cells in the process of division express both isoforms. These results suggest a potential role of the CD45RA isoform during the stages of cell cycle leading to mitosis.

MeSH Terms
Antigens, CD/analysis G2 Phase Histocompatibility Antigens/analysis Humans Leukocyte Common Antigens Mitosis S Phase T-Lymphocytes/immunology
Chemicals
Antigens, CD Histocompatibility Antigens Leukocyte Common Antigens
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
LaSalle J M
Department of Medicine, Brigham and Women's Hospital, Harvard University, Boston, Massachusetts 02115.
Hafler D A
Article Info
Journal
Cellular immunology
Abbr.
Cell Immunol
ISSN
0008-8749
Published
1991-11-00
Pages
197-206
Language
English
Region
Netherlands
NLM ID
1246405
Subset
IM
Grants
NINDS NIH HHS · KO8 NS-00981 · United States
NINDS NIH HHS · R01 NS-24247 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com